To further confirm the pattern of SLC22A3 methylation, we enrolled a larger cohort of newly diagnosed MDS (n = 61) and AML (n = 153) samples by RQ-MSP, a more convenient method. The gene discussed is SLC22A3; the disease is acute myeloid leukemia.